Design Therapeutics, Inc.
Company Stats
- Market Cap
- $786.7M
- as of Sep 30, 2026
- Shares Outstanding
- 62.6M
- Free Float
- 49.1%
Income Statement
- Revenue
- $0
- Operating Income
- -$79.5M
- Net Income
- -$69.8M
- EBITDA
- -$78.8M
Cash Flow
- Free Cash Flow
- -$54.6M
- FCF Yield
- -6.9%
- Owner FCF Yield
- -8.8%
Balance Sheet
- Cash & Equivalents
- $16.9M
Returns & Capital
- SBC, 3Y Avg
- $13.6M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $0 | -$54.6M | — |
| FY2024 | $0 | -$43.4M | — |
| FY2023 | — | -$58.8M | — |
| FY2022 | — | -$52.2M | — |
| FY2021 | — | -$30.9M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 14, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back